Edition:
United States

VIVUS Inc (VVUS.O)

VVUS.O on Nasdaq

1.10USD
26 Jul 2016
Change (% chg)

$-0.01 (-0.90%)
Prev Close
$1.11
Open
$1.13
Day's High
$1.15
Day's Low
$1.07
Volume
622,401
Avg. Vol
851,913
52-wk High
$2.25
52-wk Low
$0.92

VVUS.O

Chart for VVUS.O

About

VIVUS, Inc. is a biopharmaceutical company. The Company operates in the development and commercialization of therapeutic products segment. It provides over two therapies approved by the Food and Drug Association (FDA), which include Qsymia (phentermine and topiramate extended-release) for chronic weight management and STENDRA... (more)

Overall

Beta: 1.16
Market Cap(Mil.): $115.54
Shares Outstanding(Mil.): 104.09
Dividend: --
Yield (%): --

Financials

  VVUS.O Industry Sector
P/E (TTM): -- 36.91 37.71
EPS (TTM): -0.87 -- --
ROI: -35.86 15.22 14.43
ROE: -364.58 16.27 15.61

BRIEF-Vivus says to extend return date of Stendra commercial rights

* Vivus Inc says to extend return date of Stendra commercial rights

Jun 30 2016

BRIEF-Vivus receives notice from Hetero USA that it has filed with U.S. FDA ANDA for generic versions of all strengths of Stendra tablets

* Received notice from Hetero USA that it has filed with U.S. FDA ANDA for generic versions of all strengths of Stendra tablets

Jun 21 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.